Annual EBITDA
-$24.69 M
-$285.00 K-1.17%
December 31, 2023
Summary
- As of February 12, 2025, NVNO annual EBITDA is -$24.69 million, with the most recent change of -$285.00 thousand (-1.17%) on December 31, 2023.
- During the last 3 years, NVNO annual EBITDA has fallen by -$15.94 million (-182.16%).
- NVNO annual EBITDA is now -2020.76% below its all-time high of -$1.16 million, reached on December 31, 2015.
Performance
NVNO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$6.04 M
-$723.00 K-13.60%
September 30, 2024
Summary
- As of February 12, 2025, NVNO quarterly EBITDA is -$6.04 million, with the most recent change of -$723.00 thousand (-13.60%) on September 30, 2024.
- Over the past year, NVNO quarterly EBITDA has increased by +$103.00 thousand (+1.68%).
- NVNO quarterly EBITDA is now -9266.92% below its all-time high of $65.90 thousand, reached on March 31, 2018.
Performance
NVNO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$22.86 M
-$830.00 K-3.77%
September 30, 2024
Summary
- As of February 12, 2025, NVNO TTM EBITDA is -$22.86 million, with the most recent change of -$830.00 thousand (-3.77%) on September 30, 2024.
- Over the past year, NVNO TTM EBITDA has increased by +$1.83 million (+7.40%).
- NVNO TTM EBITDA is now -2138.81% below its all-time high of -$1.02 million, reached on September 30, 2016.
Performance
NVNO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
NVNO EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.2% | +1.7% | +7.4% |
| 3 y3 years | -182.2% | +9.3% | +11.6% |
| 5 y5 years | -308.2% | +9.3% | +11.6% |
NVNO EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -50.2% | at low | -16.0% | +31.9% | -39.1% | +15.2% |
| 5 y | 5-year | -269.1% | at low | -324.7% | +31.9% | -268.8% | +15.2% |
| alltime | all time | -2020.8% | at low | -9266.9% | +31.9% | -2138.8% | +15.2% |
EnVVeno Medical EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$6.04 M(+13.6%) | -$22.86 M(+3.8%) |
| Jun 2024 | - | -$5.32 M(-0.8%) | -$22.04 M(-5.8%) |
| Mar 2024 | - | -$5.36 M(-12.7%) | -$23.39 M(-5.3%) |
| Dec 2023 | -$24.69 M(+1.2%) | -$6.14 M(+17.9%) | -$24.69 M(-0.7%) |
| Sep 2023 | - | -$5.21 M(-21.9%) | -$24.88 M(-3.1%) |
| Jun 2023 | - | -$6.68 M(+0.2%) | -$25.68 M(-0.7%) |
| Mar 2023 | - | -$6.66 M(+5.2%) | -$25.86 M(+6.0%) |
| Dec 2022 | -$24.41 M(+48.5%) | -$6.33 M(+5.2%) | -$24.41 M(-9.4%) |
| Sep 2022 | - | -$6.02 M(-12.2%) | -$26.95 M(+14.6%) |
| Jun 2022 | - | -$6.85 M(+31.6%) | -$23.52 M(+24.1%) |
| Mar 2022 | - | -$5.21 M(-41.3%) | -$18.94 M(+15.2%) |
| Dec 2021 | -$16.44 M(+87.9%) | -$8.87 M(+242.9%) | -$16.44 M(+41.3%) |
| Sep 2021 | - | -$2.59 M(+13.5%) | -$11.63 M(+7.0%) |
| Jun 2021 | - | -$2.28 M(-15.7%) | -$10.87 M(+8.3%) |
| Mar 2021 | - | -$2.70 M(-33.4%) | -$10.03 M(+14.6%) |
| Dec 2020 | -$8.75 M | -$4.06 M(+122.8%) | -$8.75 M(+39.0%) |
| Sep 2020 | - | -$1.82 M(+26.4%) | -$6.29 M(+1.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | -$1.44 M(+1.4%) | -$6.20 M(-6.4%) |
| Mar 2020 | - | -$1.42 M(-11.4%) | -$6.62 M(-1.0%) |
| Dec 2019 | -$6.69 M(+10.6%) | -$1.61 M(-7.2%) | -$6.69 M(-2.3%) |
| Sep 2019 | - | -$1.73 M(-7.2%) | -$6.85 M(+4.2%) |
| Jun 2019 | - | -$1.86 M(+25.0%) | -$6.57 M(-13.6%) |
| Mar 2019 | - | -$1.49 M(-15.5%) | -$7.61 M(+25.7%) |
| Dec 2018 | -$6.05 M(+5.5%) | -$1.77 M(+21.4%) | -$6.05 M(+1.7%) |
| Sep 2018 | - | -$1.45 M(-49.8%) | -$5.95 M(-5.1%) |
| Jun 2018 | - | -$2.89 M(-4492.7%) | -$6.27 M(+37.1%) |
| Mar 2018 | - | $65.90 K(-104.0%) | -$4.57 M(-20.6%) |
| Dec 2017 | -$5.73 M(+6.6%) | -$1.67 M(-6.1%) | -$5.76 M(+3.1%) |
| Sep 2017 | - | -$1.78 M(+48.3%) | -$5.58 M(+15.6%) |
| Jun 2017 | - | -$1.20 M(+7.1%) | -$4.83 M(+33.0%) |
| Mar 2017 | - | -$1.12 M(-25.1%) | -$3.63 M(+44.5%) |
| Dec 2016 | -$5.38 M(+362.0%) | -$1.49 M(+46.1%) | -$2.51 M(+146.1%) |
| Sep 2016 | - | -$1.02 M | -$1.02 M |
| Dec 2015 | -$1.16 M | - | - |
FAQ
- What is enVVeno Medical annual EBITDA?
- What is the all time high annual EBITDA for enVVeno Medical?
- What is enVVeno Medical annual EBITDA year-on-year change?
- What is enVVeno Medical quarterly EBITDA?
- What is the all time high quarterly EBITDA for enVVeno Medical?
- What is enVVeno Medical quarterly EBITDA year-on-year change?
- What is enVVeno Medical TTM EBITDA?
- What is the all time high TTM EBITDA for enVVeno Medical?
- What is enVVeno Medical TTM EBITDA year-on-year change?
What is enVVeno Medical annual EBITDA?
The current annual EBITDA of NVNO is -$24.69 M
What is the all time high annual EBITDA for enVVeno Medical?
enVVeno Medical all-time high annual EBITDA is -$1.16 M
What is enVVeno Medical annual EBITDA year-on-year change?
Over the past year, NVNO annual EBITDA has changed by -$285.00 K (-1.17%)
What is enVVeno Medical quarterly EBITDA?
The current quarterly EBITDA of NVNO is -$6.04 M
What is the all time high quarterly EBITDA for enVVeno Medical?
enVVeno Medical all-time high quarterly EBITDA is $65.90 K
What is enVVeno Medical quarterly EBITDA year-on-year change?
Over the past year, NVNO quarterly EBITDA has changed by +$103.00 K (+1.68%)
What is enVVeno Medical TTM EBITDA?
The current TTM EBITDA of NVNO is -$22.86 M
What is the all time high TTM EBITDA for enVVeno Medical?
enVVeno Medical all-time high TTM EBITDA is -$1.02 M
What is enVVeno Medical TTM EBITDA year-on-year change?
Over the past year, NVNO TTM EBITDA has changed by +$1.83 M (+7.40%)